New York A 2566: Relates to certification by pharmacists of patients using medical cannabis

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A02566 Summary:

BILL NOA02566 

&nbsp

SAME ASSAME AS S05704

&nbsp

SPONSORMcDonald

&nbsp

COSPNSRLupardo, Hunter, Kelles

&nbsp

MLTSPNSR

&nbsp

Amd §30, Cannabis L

&nbsp

Relates to the content and procedure for certification by pharmacists of patients using medical cannabis; allows a pharmacist employed by a registered organization and responsible for supervising the dispensing of medical cannabis within a cannabis dispensing facility to recommend and certify patients upon consultation within such dispensing facility.

Go to top A02566 Actions:

BILL NOA02566 

&nbsp

01/17/2025referred to higher education

01/07/2026referred to higher education

Go to topA02566 Committee&nbspVotes:

Go to topA02566 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA02566 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 2566

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 17, 2025
 ___________

 Introduced by M. of A. McDONALD, LUPARDO, HUNTER -- read once and
 referred to the Committee on Higher Education

 AN ACT to amend the cannabis law, in relation to certification by phar-
 macists of patients using medical cannabis

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 30 of the cannabis law is amended to read as
 2 follows:
 3 § 30. Certification of patients. 1. A patient certification may only
 4 be issued if:
 5 (a) the patient has a condition, which shall be specified in the
 6 patient's health care record, if applicable;
 7 (b) the practitioner by training or experience is qualified to treat
 8 the condition;
 9 (c) the patient is under the practitioner's continuing care for the
 10 condition; [and] or
 11 (d) in the practitioner's professional opinion and review of past
 12 treatments, the patient is likely to receive therapeutic or palliative
 13 benefit from the primary or adjunctive treatment with medical use of
 14 cannabis for the condition.
 15 2. The certification shall include:
 16 (a) the name, date of birth and address of the patient;
 17 (b) a statement that the patient has a condition and the patient is
 18 under the practitioner's care for the condition;
 19 (c) a statement attesting that [all requirements] a requirement of
 20 subdivision one of this section [have] has been satisfied;
 21 (d) the date; and
 22 (e) the name, address, telephone number, and the signature of the
 23 certifying practitioner.
 24 The board may require by regulation that the certification shall be on
 25 a form provided by the office. The practitioner may state in the certif-

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD04111-01-5

 A. 2566 2

 1 ication that, in the practitioner's professional opinion, the patient
 2 would benefit from medical cannabis only until a specified date. [The
 3 practitioner may state in the certification that, in the practitioner's
 4 professional opinion, the patient is terminally ill and that the certif-
 5 ication shall not expire until the patient dies.]
 6 3. In making a certification, the practitioner may consider the form
 7 of medical cannabis the patient should consume, including the method of
 8 consumption and any particular strain, variety, and quantity or percent-
 9 age of cannabis or particular active ingredient, and appropriate dosage.
 10 The practitioner may state in the certification any recommendation or
 11 limitation the practitioner makes, in [his or her] the practitioner's
 12 professional opinion, concerning the appropriate form or forms of
 13 medical cannabis and dosage.
 14 4. Every practitioner shall make a reasonable effort to consult the
 15 prescription monitoring program registry prior to making or issuing a
 16 certification, for the purpose of reviewing a patient's controlled
 17 substance history. For purposes of this section, a practitioner may
 18 authorize a designee to consult the prescription monitoring program
 19 registry on [his or her] the practitioner's behalf, provided that such
 20 designation is in accordance with section thirty-three hundred forty-
 21 three-a of the public health law.
 22 5. The practitioner shall give the certification to the certified
 23 p